Form Type: 4

SEC EDGAR Link
Acccession Number:0000899243-20-014619
Date:2020-05-27
Issuer: AIMMUNE THERAPEUTICS, INC. (AIMT)
Original Submission Date:

Reporting Person:

BEHAR GREGORY
AIMMUNE THERAPEUTICS, INC.
8000 MARINA BOULEVARD, SUITE 300 BRISBANE, CA 94005-1884

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK, $0.0001 PAR VALUE 2020-05-27 A 7,840 a $0.00 18,032 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 17.11 2020-05-27 deemed execution date A 15,398 (a) 2030-05-26 common stock 15,398 $17.11 15,398 direct
Footnotes
IDfootnote
f1 these shares represent restricted stock units ("rsus") and will be settled in common stock upon vesting. the rsus vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2021 annual meeting of the issuer's stockholders, assuming continuous service as a director until such vesting date.
f2 the shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2021 annual meeting of the issuer's stockholders, assuming continuous service as a director until such vesting date.

Elevate your investments